Canine Acute Respiratory Distress Syndrome: Diagnostic Criteria and Management

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Canine ARDS is characterized by acute onset of severe hypoxemia (PaO2/FiO2 < 300 mmHg), bilateral pulmonary infiltrates on imaging, and absence of left-sided cardiac failure, typically occurring within 72 hours of a known risk factor such as sepsis, pneumonia, or aspiration.
• Diagnosis relies on a combination of clinical signs, imaging (radiography or CT), oxygenation criteria (PaO2/FiO2 ratio), and exclusion of cardiogenic edema via echocardiography to assess left atrial pressure.
• Lung-protective mechanical ventilation strategies are crucial, employing low tidal volumes (6-8 mL/kg ideal body weight) to maintain plateau pressures below 30 cm H2O and titrating positive end-expiratory pressure (PEEP) to optimize alveolar recruitment while avoiding overdistension.
• Monitoring includes serial arterial blood gases, pulse oximetry, capnography for end-tidal CO2 trends, and assessment of static compliance to guide ventilator adjustments and detect ventilator-induced lung injury.
• Supportive care encompasses nutritional support within 24-48 hours, adequate sedation and analgesia for ventilator synchrony, conservative fluid management to balance cardiac output and edema, and vigilance for complications like ventilator-associated pneumonia and barotrauma.
• Rescue therapies for refractory hypoxemia may include inhaled nitric oxide, surfactant replacement, or extracorporeal membrane oxygenation (ECMO) in specialized referral centers, while the fibroproliferative phase of ARDS responds poorly to recruitment maneuvers due to irreversible structural changes.

Canine acute respiratory distress syndrome (ARDS) is a rapidly progressive inflammatory lung injury that produces severe hypoxemia, bilateral pulmonary infiltrates, and reduced pulmonary compliance in the absence of left-sided cardiac failure. This article provides a diagnostic framework and management strategy for the practicing veterinarian, with emphasis on recognition of the syndrome, ventilator support, and supportive care. The content assumes familiarity with blood gas interpretation, mechanical ventilation, and intensive care monitoring.

The clinical question this article addresses is direct: when a dog presents with acute respiratory failure, how does the clinician distinguish ARDS from other causes of hypoxemia, and what therapeutic decisions follow from that diagnosis? The approach presented here integrates published consensus criteria, ventilator management principles derived from human ARDS research, and practical considerations for the veterinary intensive care unit. The article excludes other causes of respiratory distress such as airway obstruction, pleural space disease, and primary cardiac failure, except where they appear in the differential diagnosis.

At a Glance

Pathophysiology of Canine ARDS

ARDS represents the pulmonary manifestation of a systemic inflammatory response. The inciting event may be direct, such as pneumonia, aspiration, or thoracic trauma, or indirect, such as sepsis, pancreatitis, or severe systemic inflammation. Regardless of the trigger, the final common pathway involves damage to the alveolar-capillary membrane, leading to increased permeability, protein-rich edema fluid in the alveoli, and influx of neutrophils and other inflammatory cells.

The inflammatory cascade that drives ARDS involves multiple mediator systems. The inflammasome pathway, particularly caspase-1 and its downstream cytokines including interleukin-18, has been identified as a critical mediator of acute lung injury in experimental models and in human patients with ARDS, as described in research on inflammasome-regulated cytokines in acute lung injury. Mechanical ventilation itself can amplify this inflammatory response, a phenomenon that underpins the current emphasis on lung-protective ventilator strategies.

The exudative phase of ARDS, characterized by alveolar edema and hyaline membrane formation, may progress to a fibroproliferative phase in which fibroblast proliferation and collagen deposition remodel the lung architecture. Animal models of fibrotic lung disease demonstrate that the transition from acute injury to fibrosis is influenced by the severity and duration of the initial insult, as well as by host factors including age. This progression has important prognostic implications in dogs, although the time course appears more compressed than in human patients.

Diagnostic Criteria

The diagnosis of ARDS in dogs rests on a combination of clinical, imaging, and oxygenation criteria. The veterinary-specific criteria, published by the American College of Veterinary Internal Medicine (ACVIM) as part of its consensus statement process, require acute onset of respiratory signs, bilateral pulmonary infiltrates on imaging, evidence of impaired oxygenation, and exclusion of cardiogenic pulmonary edema.

The oxygenation criterion is expressed as the ratio of arterial partial pressure of oxygen to the fraction of inspired oxygen (PaO2/FiO2). A ratio below 300 mm Hg with an FiO2 of 0.21 or higher supports the diagnosis. In dogs that are not intubated, the FiO2 can be estimated as 0.21 for room air, but once supplemental oxygen is administered, the calculation requires knowledge of the delivered FiO2. This measurement should be obtained with the dog breathing a stable FiO2 for at least 10 minutes before arterial sampling.

Exclusion of cardiogenic edema is essential. Thoracic radiographs typically show a diffuse alveolar or interstitial pattern that may be indistinguishable from cardiogenic edema. Echocardiography is the most reliable method for assessing left atrial pressure, and a dog with normal left atrial size and no evidence of left-sided valvular disease or myocardial failure can be considered to meet the cardiac exclusion criterion. Point-of-care ultrasound of the lungs may reveal B-lines and consolidation, but these findings do not distinguish ARDS from cardiogenic edema.

Risk Factors and Clinical Presentation

Dogs that develop ARDS almost always have a recognizable predisposing condition. Sepsis, severe pneumonia, aspiration of gastric contents, major trauma, and systemic inflammatory response syndrome are the most commonly reported antecedents. Less frequently, ARDS follows massive blood transfusion, heat stroke, or severe pancreatitis. The absence of any identifiable risk factor should prompt reconsideration of the diagnosis, although idiopathic ARDS has been reported.

The typical presentation is a dog with an established critical illness that develops acute worsening of respiratory effort over hours. Tachypnea, increased respiratory effort, and cyanosis or pallor are common. Crackles may be audible on thoracic auscultation, but the absence of adventitious sounds does not exclude the diagnosis. Arterial blood gas analysis reveals hypoxemia that is poorly responsive to supplemental oxygen, and the dog often requires escalating FiO2 to maintain acceptable oxygen saturation.

Ventilator-Induced Lung Injury

Mechanical ventilation, while necessary to support oxygenation and ventilation in severe ARDS, can itself perpetuate lung injury. Ventilator-induced lung injury results from overdistension of alveoli, cyclic opening and closing of atelectatic lung units, and the release of inflammatory mediators. The concept that high tidal volumes and high airway pressures are deleterious is supported by experimental and clinical evidence. A multicenter trial in human ARDS patients comparing a strategy that limited plateau pressure to 25 cm H2O with tidal volumes below 10 mL/kg against conventional ventilation found that the reduced tidal volume strategy did not improve survival, but the study also demonstrated that the two groups achieved similar oxygenation despite markedly different ventilator settings. This finding contributed to the recognition that oxygenation alone is an inadequate target for ventilator adjustment.

The inflammatory response to mechanical ventilation is mediated in part by the same inflammasome pathways that drive the initial lung injury. Research in mice has shown that mechanical ventilation at moderate tidal volumes increases interleukin-18 levels in lung tissue and serum, and that blockade of this pathway reduces lung injury. These observations provide a mechanistic rationale for ventilator strategies that minimize alveolar strain.

Oxygenation Targets and Monitoring

The central therapeutic objective in canine ARDS is maintaining tissue oxygen delivery while avoiding additional iatrogenic lung injury. No single oxygenation value defines adequate support for every patient. The clinician must integrate arterial blood gas analysis, pulse oximetry, and clinical perfusion parameters into a coherent picture that changes over time.

Arterial blood gas analysis remains the reference standard. The PaO₂ to FiO₂ ratio (P/F ratio) tracks the severity of gas exchange impairment and the response to therapy. A P/F ratio below 300 indicates acute lung injury, and below 200 defines ARDS under the veterinary consensus criteria. Serial measurements every 4 to 6 hours during the unstable phase allow titration of FiO₂ and positive end-expiratory pressure (PEEP). Pulse oximetry provides continuous trend monitoring but becomes unreliable when peripheral perfusion is poor, when the patient is vasoconstricted, or when methemoglobin is present. SpO₂ targets of 94 to 98 percent generally correspond to a PaO₂ of 80 to 100 mmHg in dogs with normal hemoglobin affinity.

Capnography measures exhaled carbon dioxide and provides a noninvasive estimate of arterial PaCO₂ when ventilation-perfusion matching is stable. In ARDS, the gradient between end-tidal and arterial CO₂ widens because of increased dead space, so capnography trends must be interpreted with periodic arterial blood gas confirmation. A rising end-tidal to arterial CO₂ gradient can signal worsening dead space from progressive lung injury or from excessive PEEP compressing alveolar capillaries.

Lactate concentration and central venous oxygen saturation (ScvO₂) reflect the balance between oxygen delivery and consumption. A rising lactate or falling ScvO₂ despite adequate PaO₂ suggests that cardiac output or hemoglobin concentration is limiting delivery. These parameters guide decisions about fluid therapy, vasopressor support, and blood product administration in the patient with concurrent shock.

Ventilator Management Decision Framework

Mechanical ventilation in canine ARDS follows the same lung-protective principles established in human critical care. The goal is to recruit collapsed alveoli and maintain them open with PEEP while using tidal volumes that avoid overdistension of the remaining aerated lung. The human literature demonstrates that limiting end-inspiratory plateau pressure and tidal volume reduces ventilator-induced lung injury, although the optimal strategy in dogs continues to be refined through clinical experience and extrapolation from human trials such as the tidal volume reduction study by Brochard and colleagues (1998).

Permissive hypercapnia is an accepted consequence of low tidal volume ventilation. The clinician accepts a higher PaCO₂ to protect the lung from volutrauma, provided the arterial pH remains above 7.20. Contraindications to permissive hypercapnia include concurrent intracranial disease, severe pulmonary hypertension, and refractory hypotension, where the vasodilatory effects of CO₂ may be poorly tolerated.

Plateau pressure is measured during a 0.5 second end-inspiratory pause and reflects the pressure distending the alveoli at end inspiration. It is the primary monitor for overdistension. Peak inspiratory pressure includes the resistance of the airways and endotracheal tube, so it can be elevated by bronchospasm, secretions, or a kinked tube without indicating alveolar overdistension. A widening gap between peak and plateau pressure should prompt evaluation of the airway instead of a change in tidal volume.

Recruitment Maneuvers and PEEP Titration

Refractory hypoxemia from diffuse alveolar collapse may respond to a recruitment maneuver. The most commonly used technique in dogs is a sustained inflation to 30 to 40 cm H₂O for 30 to 60 seconds, followed by a return to the previous PEEP level. Recruitment is most effective early in the disease course when alveolar collapse is due to atelectasis and edema instead of fibrosis. The fibroproliferative phase of ARDS responds poorly to recruitment, as the structural changes are no longer reversible by airway pressure alone, a distinction supported by experimental models of fibrotic lung disease (2013).

Recruitment maneuvers carry real risk. Hypotension from reduced venous return, pneumothorax from alveolar rupture, and worsening oxygenation from overdistension of already open lung units are the principal complications. The maneuver should be aborted immediately if systolic blood pressure falls below 80 mmHg, if arrhythmias develop, or if SpO₂ declines. Patients with preexisting bullae, recent thoracic surgery, or known pneumothorax should not undergo recruitment.

After recruitment, PEEP is titrated downward in 1 to 2 cm H₂O steps while monitoring oxygenation and compliance. The optimal PEEP is the lowest level that maintains the recruited state, identified by a stable P/F ratio and static compliance. A decremental PEEP trial, where PEEP is reduced stepwise and the response observed over 10 to 15 minutes at each level, provides a systematic method for finding this value. The clinician should document the PEEP level, the corresponding P/F ratio, and the static compliance at each step to identify the point of derecruitment.

Rescue Therapies for Refractory Hypoxemia

When lung-protective ventilation fails to maintain adequate oxygenation despite FiO₂ above 60 percent and PEEP above 10 cm H₂O, rescue therapies should be considered. Inhaled nitric oxide produces selective pulmonary vasodilation in ventilated lung units, improving ventilation-perfusion matching and oxygenation. The effect is often rapid but may wane over 24 to 48 hours. Inhaled nitric oxide requires specialized delivery equipment and monitoring for methemoglobinemia and rebound pulmonary hypertension on withdrawal.

Surfactant replacement therapy has been investigated in veterinary patients but remains limited by cost, availability, and the need for repeated dosing. The evidence base in dogs is largely extrapolated from experimental models and human neonatal practice. Clinical response is variable, and the therapy is most likely to benefit patients early in the disease course with primary surfactant deficiency or inactivation.

Extracorporeal membrane oxygenation (ECMO) is available at a small number of referral centers for dogs with reversible ARDS refractory to conventional ventilation. Patient selection requires careful assessment of underlying disease, expected duration of support, and owner commitment. ECMO does not treat the underlying pulmonary pathology, it provides time for the lung to heal while avoiding the additional injury of high-pressure ventilation.

Supportive Care and Complications

Nutritional support should begin within 24 to 48 hours of admission unless the patient is hemodynamically unstable. Enteral feeding preserves gut barrier function and reduces bacterial translocation. The role of immunonutrition with omega-3 fatty acids and antioxidants in ARDS remains an area of active investigation. A randomized controlled trial in human ARDS patients demonstrated improved oxygenation and reduced pulmonary inflammation with a diet supplemented with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants (1999), but comparable veterinary studies are lacking. Standard enteral formulas are appropriate for most canine patients until species-specific evidence becomes available.

Sedation and analgesia are mandatory for ventilator synchrony. A continuous infusion of a benzodiazepine combined with an opioid provides the foundation, with neuromuscular blocking agents reserved for patients with refractory dyssynchrony or profoundly elevated plateau pressures. Neuromuscular blockade eliminates the cough reflex and requires meticulous eye care, recumbency management, and monitoring for corneal ulceration and pressure sores.

Ventilator-associated pneumonia is a constant threat in the intubated patient. Daily assessment of lung sounds, serial thoracic radiographs, and monitoring of endotracheal tube secretions for changes in volume, color, or odor guide early diagnosis. A sudden deterioration in oxygenation or compliance should prompt evaluation for pneumothorax, endotracheal tube obstruction, or pulmonary embolism before assuming progression of the underlying ARDS.

Fluid management in ARDS balances the need for adequate cardiac output against the risk of worsening pulmonary edema. A conservative fluid strategy, using balanced crystalloids at maintenance rates and vasopressors to support blood pressure when needed, is generally preferred once initial resuscitation is complete. Daily body weight, urine output, and central venous pressure trends guide adjustments. The clinician should document the fluid balance each day and reassess the strategy when cumulative positive balance exceeds 10 percent of body weight.

Complications and Failure Modes

Mechanical ventilation in canine ARDS carries predictable complications. Barotrauma, volutrauma, and atelectrauma remain the principal ventilator-associated injuries, and their detection requires disciplined monitoring of airway pressures, tidal volumes, and serial radiographs. Pneumothorax presents with sudden deterioration in oxygenation, rising peak inspiratory pressure, and loss of breath sounds, thoracic ultrasound or radiography confirms the diagnosis. Immediate decompression is life-saving.

Ventilator-associated pneumonia develops in dogs ventilated beyond 48 to 72 hours. Daily assessment of fever, leukocyte trends, and tracheal aspirate cytology helps distinguish colonization from infection. A new infiltrate on radiographs combined with purulent secretions and a positive culture supports the diagnosis. Empirical antimicrobial therapy should follow current formulary guidance and be refined once culture results return.

Oxygen toxicity becomes relevant when fractional inspired oxygen exceeds 0.6 for prolonged periods. Serial arterial blood gas analysis should guide downward titration of oxygen as soon as oxygenation permits. Refractory hypoxemia despite optimal ventilation warrants reassessment of the underlying trigger, not simply escalation of support.

Fluid overload is a common iatrogenic complication. Capillary refill time, body weight trends, urine output, and central venous pressure provide complementary signals. Lung ultrasound for B-lines can detect interstitial edema earlier than radiography. Diuretic therapy should be considered when fluid balance becomes positive without corresponding improvement in perfusion.

Common Errors in Management

Less experienced clinicians frequently misclassify the phase of ARDS. The exudative phase demands lung-protective ventilation and fluid restriction, whereas the fibroproliferative phase may require different nutritional and ventilatory strategies. Serial radiographs and oxygenation trends help distinguish these phases.

Errors in ventilator settings are common. Excessive tidal volumes, inadequate positive end-expiratory pressure, and failure to tolerate permissive hypercapnia all worsen lung injury. The corrective action is to target plateau pressures below 30 cm H2O and accept arterial carbon dioxide elevation when necessary to protect the lung. A second common error is weaning sedation before ventilator synchrony is confirmed, leading to patient-ventilator dyssynchrony and further lung injury.

Failure to recognize the systemic nature of ARDS is another recurring mistake. Dogs with ARDS frequently develop acute kidney injury, coagulopathy, and gastrointestinal dysfunction. Monitoring urine output, coagulation parameters, and gastric residual volumes should be routine.

Limitations of Current Evidence

The veterinary evidence base for ARDS management remains largely extrapolated from human medicine. The landmark human trials demonstrating reduced mortality with low tidal volume ventilation have no direct canine equivalent. The tidal volume reduction trial in human ARDS patients showed no mortality benefit at day 60, although it confirmed the feasibility of lower tidal volume strategies. This finding tempers the assumption that lung-protective ventilation necessarily improves survival in dogs.

Nutritional support in ARDS is similarly extrapolated. A randomized trial of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in human ARDS patients demonstrated improved oxygenation, but no comparable veterinary study exists. Whether these benefits translate to dogs with different inflammatory profiles remains uncertain.

The role of immunomodulatory therapy is contested. The inflammasome-regulated cytokine pathway has been identified as a mediator of acute lung injury in experimental models, and cytokine storm mechanisms are well described in human coronavirus infections. However, targeted anticytokine therapy has not been validated in canine ARDS, and expert opinion differs on whether such approaches merit clinical use outside a research setting.

Expert consensus statements from the American College of Veterinary Internal Medicine provide practical guidance where controlled trials are absent. These documents acknowledge that many recommendations reflect expert opinion instead of high-grade evidence.

Referral and Escalation

Dogs with suspected ARDS should be referred to a facility with 24-hour critical care and mechanical ventilation capability before respiratory failure becomes refractory. Early referral is preferable to emergency transfer of an unstable, ventilated patient. Indications for immediate referral include progressive hypoxemia despite supplemental oxygen, respiratory rate exceeding 60 breaths per minute with increased effort, and evidence of impending fatigue.

Specialist consultation with a veterinary criticalist or anesthesiologist is warranted when ventilator settings exceed initial parameters, when oxygenation fails to improve within 24 hours, or when complications such as pneumothorax or ventilator-associated pneumonia arise. Laboratory involvement may include serial blood gas analysis, coagulation panels, and advanced diagnostics to identify the underlying trigger.

Regulatory reporting obligations vary by jurisdiction. Certain infectious causes of ARDS, including zoonotic pathogens, may require notification to public health authorities. The World Organization for Animal Health terrestrial animal health standards describe reporting requirements for notifiable diseases, and the American Veterinary Medical Association practice resources provide guidance on professional obligations. Clinicians should confirm local requirements with their regulatory body.

Frequently Asked Questions

How Do I Manage Suspected ARDS When Mechanical Ventilation Is Not Available?

When a ventilator is unavailable, focus on oxygen supplementation, treating the underlying trigger, and minimizing additional lung injury. Flow-by oxygen, mask oxygen, or oxygen cages can provide short-term support, but they cannot reliably deliver the precise FiO2 control or positive end-expiratory pressure that ARDS requires. Manual ventilation with a self-inflating bag and attached positive end-expiratory pressure valve is a temporizing measure only. Consider early referral before the patient fatigues, because transport on supplemental oxygen may be feasible when the patient is stable enough to move. If referral is impossible, discuss the guarded prognosis honestly with the owner and prioritize comfort. The MSD Veterinary Manual provides general guidance on oxygen therapy and respiratory support in dogs.

What Is the Minimum Monitoring Equipment Needed to Ventilate an ARDS Patient Safely?

A mechanical ventilator alone is insufficient. You need a continuous capnograph, a pulse oximeter, an arterial blood gas analyzer or a validated venous blood gas alternative, a noninvasive blood pressure monitor, and an electrocardiogram. A ventilator that displays tidal volume, peak inspiratory pressure, plateau pressure, and positive end-expiratory pressure is essential. Without plateau pressure measurement, you cannot assess lung compliance or titrate volume to avoid overdistension. If arterial sampling is not possible, venous blood gas with concurrent pulse oximetry can guide trends, but this is a compromise. The ACVIM consensus statements emphasize that institutional protocols and available resources should shape the level of monitoring offered.

How Should I Document Ventilator Settings and Changes in the Medical Record?

Record ventilator settings at least hourly, including mode, tidal volume, respiratory rate, FiO2, positive end-expiratory pressure, peak inspiratory pressure, plateau pressure, and measured exhaled tidal volume. Document every setting change with the time, the reason, and the patient response. Arterial blood gas results should be recorded with the corresponding ventilator settings and the time of sampling. Also document sedation scores, spontaneous breathing effort, and any episodes of desynchrony or disconnection. Serial compliance calculations, when performed, belong in the record because they track disease progression. The AVMA practice resources advise that complete and contemporaneous records support continuity of care and defensible clinical decisions.

What Do I Tell an Owner When Discussing Prognosis and Cost?

Be direct about the uncertainty. Explain that ARDS carries a high mortality rate even with optimal ventilator care, that the hospital stay is typically prolonged, and that costs accumulate daily. Describe the ventilator as a support device that gives the lungs time to heal, not a cure. Mention that some dogs wean successfully while others develop progressive respiratory failure or complications such as barotrauma or nosocomial pneumonia. Provide a realistic range of expected duration and cost before admission if possible, and revisit the discussion every 24 to 48 hours. The MSD Veterinary Manual offers general guidance on prognosis discussions, but individual outcomes remain difficult to predict.

How Does Canine ARDS Management Differ From Human ARDS Protocols?

Human ARDS protocols are based on large randomized trials, including the landmark tidal volume reduction study that compared lower versus conventional tidal volumes in adults. Canine ARDS is less studied, and most recommendations are extrapolated from human medicine and experimental models. Dogs differ in lung mechanics, body conformation, and the common underlying triggers, which include aspiration, sepsis, and pancreatitis. The ACVIM consensus statements provide veterinary-specific guidance where it exists, but clinicians must accept that the evidence base is thinner and that individual titration based on serial blood gases and compliance is mandatory.

When Should I Stop Ventilator Support or Recommend Euthanasia?

Decide on predefined criteria before starting ventilation. These include failure to achieve oxygenation targets despite maximal support, progressive hypotension refractory to vasopressors, worsening compliance over 48 to 72 hours, or development of irreversible complications such as refractory pneumothorax. If the underlying disease is progressive and untreatable, continued ventilation prolongs suffering without benefit. Fibrotic changes can occur after acute lung injury and may make recovery impossible even if the patient survives the acute phase. Discuss these criteria with the owner at admission so that decisions are not made in crisis. The ACVIM consensus statements support a structured approach to withdrawal of support when treatment goals cannot be met.

Related Clinical & Scientific Guides

• Feline Hepatic Lipidosis: Nutritional and Medical Management
• Canine Respiratory Infection: Diagnostic Approach and Treatment
• Canine Respiratory Virus: Diagnostic and Management Considerations

References and Further Reading

• Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.. 1999.
• Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.. 2017.
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.. 2020.
• Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS.. 1998.
• Animal models of fibrotic lung disease.. 2013.
• Inflammasome-regulated cytokines are critical mediators of acute lung injury.. 2012.
• ACVIM Consensus Statements. Journal of Veterinary Internal Medicine.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Canine Respiratory Distress: Emergency Diagnostic and Stabilization
• Canine Respiratory Virus: Diagnostic and Management Considerations
• Canine Lower Respiratory Disease: Diagnostic and Management Strategy
• Canine Proteinuria: Diagnostic Approach and Management
• Canine Vestibular Syndrome: Differential Diagnosis and Management

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.